Trials / Sponsors / A2A Pharmaceuticals Inc.
A2A Pharmaceuticals Inc.
Industry · 1 registered clinical trial — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors With or Solid Tumor Malignancies, Brain Metastases From Solid Tumors | Phase 1 | 2023-11-02 |